Fresenius Expands NxStage and Nx2me Agreement with DaVita

With its remote capabilities and connectivity, the NxStage home HD machine and health platform is something that DaVita plans to grow with. DaVita Group VP for Home Modalities notes that the company aims to support “patients’ desire to stay on their treatment of choice longer,” and Joe Turk, President of Home and Critical Care Therapies for Fresenius is “excited to expand our longstanding colalboration with DaVita to help more patients benefit from the portability, dependability, and flexibility of our NxStage home machines.”

Read the full article » | Posted 04-16-2021

Related Articles

• Watch a 2-minute video of Dr. Brigitte Schiller describing a paper on nocturnal home HD Posted 08-21-2026
• The Quanta Dialysis System for home HD is the first FDA 510(k) approved machine that offers high (500 mL/min) dialysate flow Posted 08-21-2026
• The American Kidney Fund’s Kidney Action Week: Future of Kidney Care is September 8-10. Posted 08-21-2026
• On August 9, CMS published “Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment.” Posted 08-21-2026